T-cell lymphoma classification: Difference between revisions
| Line 14: | Line 14: | ||
Based on the duration of symptoms, [disease name] may be classified as either acute or chronic. | Based on the duration of symptoms, [disease name] may be classified as either acute or chronic. | ||
If the staging system involves specific and characteristic findings and features: | If the staging system involves specific and characteristic findings and features: | ||
| Line 22: | Line 20: | ||
OR | OR | ||
The staging of [malignancy name] is based on the [staging system]. | The staging of [malignancy name] is based on the [staging system].. | ||
==Classification== | ==Classification== | ||
Revision as of 16:13, 29 October 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2]
Overview
Tcell lymphoma may be classified according to The 2016 WHO update on mature T- and natural killer (NK) cell neoplasms.
OR
[Disease name] may be classified into [large number > 6] subtypes based on [classification method 1], [classification method 2], and [classification method 3]. [Disease name] may be classified into several subtypes based on [classification method 1], [classification method 2], and [classification method 3].
OR
Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
If the staging system involves specific and characteristic findings and features: According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
OR
The staging of [malignancy name] is based on the [staging system]..
Classification
According to the the 2017 revision of the World Health Organization classification of lymphoid neoplasms classified there are four clinical variants of adult T cell leukemia-lymphoma (ATL).[1]
- T cell prolymphocytic leukemia
- T cell large granular lymphocytic leukemia
- Aggressive NK cell leukemia
- Systemic EBV+ T cell lymphoma of childhood*
- Hydroa vacciniforme-like lymphoproliferative disorder*
- Adult T cell leukemia/lymphoma
- Extranodal NK/T cell lymphoma, nasal type
- Enteropathy-associated T cell lymphoma
- Monomorphic epitheliotropic intestinal T cell lymphoma*
- Hepatosplenic T cell lymphoma
- Subcutaneous panniculitis-like T cell lymphoma
- Mycosis fungoides
- Sézary syndrome
- Primary cutaneous CD30+ T cell lymphoproliferative disorders
- Lymphomatoid papulosis
- Primary cutaneous anaplastic large cell lymphoma
- Primary cutaneous γδ T cell lymphoma
- Peripheral T cell lymphoma, NOS
- Angioimmunoblastic T cell lymphoma
- Anaplastic large cell lymphoma, ALK+
- Anaplastic large cell lymphoma, ALK–
References
- ↑ Matutes, E. (2018). "The 2017 WHO update on mature T- and natural killer (NK) cell neoplasms". International Journal of Laboratory Hematology. 40: 97–103. doi:10.1111/ijlh.12817. ISSN 1751-5521.